Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers
- PMID: 24676844
- DOI: 10.1007/s00198-014-2676-7
Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers
Abstract
This study examined whether markers of bone turnover differ between individuals with and without diabetes. Bone markers showed heterogeneity between studies and were discrepant for markers of bone creation and markers of bone degradation. Bone markers may be of lesser value in diabetes due to heterogeneity.
Introduction: The aim of this meta-analysis was to compare existing literature regarding changes in bone markers among diabetics compared to healthy controls. To exclude that blood glucose levels among diabetes patients could influence the assays used for determining bone turnover markers, a methodological study was performed.
Methods: Medline at Pubmed Embase, Cinahl, Svemed+, Cochrane library, and Bibliotek.dk was searched in August 2012. The studies should examine biochemical bone turnover among diabetes patients in comparison to controls in an observational design. In the methodological study, fasting blood samples were drawn from two individuals. Glucose was added to the blood samples in different concentrations and OC, CTX, and procollagen type 1 amino terminal propeptide were measured after 0, 1, 2, and 3 h.
Results: Twenty-two papers fulfilled the criteria for the meta-analysis. From the pooled data in the meta-analysis, the bone markers osteocalcin (OC) (-1.15 ng/ml [-1.78,-0.52]) and C-terminal cross-linked telopeptide (CTX) (-0.14 ng/ml [-0.22, -0.05]) were significantly lower among diabetes patients than non-diabetes patients, however other markers did not differ. All markers displayed very high heterogeneity by I2 statistics. In the methodological study, the addition of glucose did not significantly change the bone markers neither by level of glucose nor with increasing incubation time.
Conclusion: The dissociative pattern of biochemical bone markers of bone formation and bone resorption present in diabetes patients is thus not caused by glucose per se but may be modulated by unknown factors associated with diabetes mellitus.
Similar articles
-
Differences in biochemical bone markers by diabetes type and the impact of glucose.Bone. 2016 Feb;83:149-155. doi: 10.1016/j.bone.2015.11.004. Epub 2015 Nov 10. Bone. 2016. PMID: 26555635
-
Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.Geriatr Gerontol Int. 2017 May;17(5):773-778. doi: 10.1111/ggi.12785. Epub 2016 May 2. Geriatr Gerontol Int. 2017. PMID: 27137883
-
Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus.J Diabetes Res. 2020 Aug 10;2020:6191468. doi: 10.1155/2020/6191468. eCollection 2020. J Diabetes Res. 2020. PMID: 32851096 Free PMC article.
-
Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review.Pediatr Diabetes. 2019 Aug;20(5):510-522. doi: 10.1111/pedi.12853. Epub 2019 May 22. Pediatr Diabetes. 2019. PMID: 30941847
-
Circulating biochemical markers of bone remodeling in uremic patients.Kidney Int. 1999 Jun;55(6):2141-56. doi: 10.1046/j.1523-1755.1999.00461.x. Kidney Int. 1999. PMID: 10354264 Review.
Cited by
-
Prolactin is associated with bone mineral density in subjects with type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2022 Oct 12;13:964808. doi: 10.3389/fendo.2022.964808. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36313749 Free PMC article.
-
Diabetes and Abdominal Aortic Calcification-a Systematic Review.Curr Osteoporos Rep. 2018 Feb;16(1):42-57. doi: 10.1007/s11914-018-0418-z. Curr Osteoporos Rep. 2018. PMID: 29380116
-
The effects of resistance training on bone mineral density and bone quality in type 2 diabetic rats.Physiol Rep. 2019 Mar;7(6):e14046. doi: 10.14814/phy2.14046. Physiol Rep. 2019. PMID: 30916457 Free PMC article.
-
Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.Endocrine. 2018 Jun;60(3):373-383. doi: 10.1007/s12020-018-1548-x. Epub 2018 Feb 6. Endocrine. 2018. PMID: 29411304
-
Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH.Calcif Tissue Int. 2022 Dec;111(6):587-596. doi: 10.1007/s00223-022-01022-7. Epub 2022 Oct 3. Calcif Tissue Int. 2022. PMID: 36190530 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical